1. Home
  2. ADMA vs SLVM Comparison

ADMA vs SLVM Comparison

Compare ADMA & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • SLVM
  • Stock Information
  • Founded
  • ADMA 2004
  • SLVM 1898
  • Country
  • ADMA United States
  • SLVM United States
  • Employees
  • ADMA N/A
  • SLVM N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • SLVM Paper
  • Sector
  • ADMA Health Care
  • SLVM Basic Materials
  • Exchange
  • ADMA Nasdaq
  • SLVM Nasdaq
  • Market Cap
  • ADMA 3.8B
  • SLVM 3.5B
  • IPO Year
  • ADMA N/A
  • SLVM N/A
  • Fundamental
  • Price
  • ADMA $16.90
  • SLVM $76.97
  • Analyst Decision
  • ADMA Strong Buy
  • SLVM Hold
  • Analyst Count
  • ADMA 4
  • SLVM 3
  • Target Price
  • ADMA $21.25
  • SLVM $89.00
  • AVG Volume (30 Days)
  • ADMA 2.5M
  • SLVM 258.6K
  • Earning Date
  • ADMA 02-26-2025
  • SLVM 02-12-2025
  • Dividend Yield
  • ADMA N/A
  • SLVM 2.33%
  • EPS Growth
  • ADMA N/A
  • SLVM N/A
  • EPS
  • ADMA 0.28
  • SLVM 6.41
  • Revenue
  • ADMA $382,809,000.00
  • SLVM $3,767,000,000.00
  • Revenue This Year
  • ADMA $66.90
  • SLVM $3.31
  • Revenue Next Year
  • ADMA $13.76
  • SLVM N/A
  • P/E Ratio
  • ADMA $60.29
  • SLVM $12.04
  • Revenue Growth
  • ADMA 63.39
  • SLVM 2.25
  • 52 Week Low
  • ADMA $5.02
  • SLVM $44.94
  • 52 Week High
  • ADMA $23.64
  • SLVM $98.02
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 48.60
  • SLVM 39.45
  • Support Level
  • ADMA $15.70
  • SLVM $78.21
  • Resistance Level
  • ADMA $16.60
  • SLVM $82.04
  • Average True Range (ATR)
  • ADMA 0.69
  • SLVM 1.80
  • MACD
  • ADMA 0.10
  • SLVM 0.06
  • Stochastic Oscillator
  • ADMA 77.17
  • SLVM 3.42

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About SLVM Sylvamo Corporation

Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America.

Share on Social Networks: